We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
RIPL specialises in the diagnosis and management of unusual or hazardous infectious diseases present in the UK or imported into the country.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
UKAEA’s Lithium Breeding Tritium Innovation (LIBRTI) programme announces significant steps to fast-track fusion fuel development.
A range of tests are available from the majority of PHE regional clinical microbiology laboratories.
Keep up to date with the latest information from the UK GLP monitoring authority.
VMD response to concerns raised following media reports of serious adverse events in dogs administered Librela.
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
How to prepare for implementation and compliance of the Safety Features Regulation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).